Covenant Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,989
| Closed | -$367K | – | 150 |
|
|
2024
Q4 | $367K | Sell |
1,989
-598
| -23% | -$110K | 0.11% | 97 |
|
|
2024
Q3 | $510K | Hold |
2,587
| – | – | 0.15% | 86 |
|
|
2024
Q2 | $534K | Hold |
2,587
| – | – | 0.16% | 87 |
|
|
2024
Q1 | $701K | Sell |
2,587
-65
| -2% | -$17.6K | 0.2% | 67 |
|
|
2023
Q4 | $627K | Hold |
2,652
| – | – | 0.2% | 79 |
|
|
2023
Q3 | $520K | Hold |
2,652
| – | – | 0.19% | 93 |
|
|
2023
Q2 | $558K | Hold |
2,652
| – | – | 0.2% | 84 |
|
|
2023
Q1 | $535K | Sell |
2,652
-669
| -20% | -$135K | 0.21% | 83 |
|
|
2022
Q4 | $724K | Hold |
3,321
| – | – | 0.29% | 58 |
|
|
2022
Q3 | $654K | Hold |
3,321
| – | – | 0.32% | 62 |
|
|
2022
Q2 | $711K | Hold |
3,321
| – | – | 0.33% | 62 |
|
|
2022
Q1 | $943K | Sell |
3,321
-485
| -13% | -$138K | 0.38% | 50 |
|
|
2021
Q4 | $1.43M | Hold |
3,806
| – | – | 0.53% | 34 |
|
|
2021
Q3 | $1.57M | Hold |
3,806
| – | – | 0.62% | 23 |
|
|
2021
Q2 | $1.41M | Hold |
3,806
| – | – | 0.53% | 30 |
|
|
2021
Q1 | $1.1M | Sell |
3,806
-394
| -9% | -$114K | 0.44% | 41 |
|
|
2020
Q4 | $1.05M | Hold |
4,200
| – | – | 0.44% | 47 |
|
|
2020
Q3 | $951K | Sell |
4,200
-881
| -17% | -$199K | 0.46% | 43 |
|
|
2020
Q2 | $886K | Buy |
5,081
+337
| +7% | +$58.8K | 0.41% | 51 |
|
|
2020
Q1 | $599K | Buy |
4,744
+103
| +2% | +$13K | 0.32% | 70 |
|
|
2019
Q4 | $709K | Hold |
4,641
| – | – | 0.33% | 66 |
|
|
2019
Q3 | $614K | Hold |
4,641
| – | – | 0.33% | 75 |
|
|
2019
Q2 | $659K | Hold |
4,641
| – | – | 0.35% | 68 |
|
|
2019
Q1 | $674K | Buy |
+4,641
| New | +$674K | 0.37% | 60 |
|